SUMMER JORDAN: Open Payments
NPI 1386313039 · SPRING HILL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,624 in 137 payments from 41 companies in 2025. Trend: 2023 $514 · 2024 $631 · 2025 $3,624
Food & beverage: $3,033Education: $591
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $365 |
| Regeneron Healthcare Solutions, Inc. | 10 | $307 |
| Novartis Pharmaceuticals Corporation | 11 | $222 |
| Astellas Pharma US Inc | 3 | $214 |
| Incyte Corporation | 9 | $211 |
| Merck Sharp & Dohme LLC | 8 | $198 |
| SEAGEN INC. | 2 | $192 |
| AstraZeneca Pharmaceuticals LP | 8 | $191 |
| GlaxoSmithKline, LLC. | 6 | $141 |
| E.R. Squibb & Sons, L.L.C. | 6 | $129 |
Products named: LIBTAYO, KEYTRUDA, CARVYKTI, Enhertu, RYBREVANT, OPDIVO, ERLEADA, JAKAFI.
Industry payments across FL — which companies pay providers there.
